Welcome to our dedicated page for American Well Corporation news (Ticker: AMWL), a resource for investors and traders seeking the latest updates and insights on American Well Corporation stock.
American Well Corporation (NYSE: AMWL), commonly known as Amwell, is a pioneering force in the telehealth industry, delivering comprehensive digital healthcare solutions both in the United States and globally. Amwell integrates providers, insurers, patients, and innovators through its state-of-the-art hybrid care enablement platform, aimed at providing greater access to more affordable and high-quality care.
Amwell’s platform supports a wide range of telehealth needs, encompassing urgent care, acute and post-acute care, behavioral health, chronic care management, and healthy living. With nearly two decades of expertise, the company powers digital care solutions for over 2,000 hospitals and 55 health plan partners, collectively reaching over 100 million covered lives.
In recent developments, Amwell has showcased impressive growth and resilience. Their third quarter of 2023 revenue totaled $61.9 million, with notable achievements such as a net loss reduction and an improved Adjusted EBITDA. The company recently secured a significant contract to support the U.S. Defense Health Agency’s Digital First initiatives, underlining the robustness and scalability of their Converge™ platform.
Another milestone was the recognition of SilverCloud®, Amwell’s digital mental health platform, with three prestigious healthcare honors. SilverCloud continues to make a significant impact in mental health support globally, offering 24/7 access to therapeutic care.
In addition, Amwell is actively pursuing innovative partnerships, such as the collaboration with Amplar Health in Australia to expand digital care and chronic disease prevention programs. This partnership emphasizes Amwell’s dedication to proactive healthcare models that leverage patient-generated data for improved outcomes.
Despite challenges, including compliance with NYSE listing standards and competitive pressures, Amwell remains committed to evolving its platform capabilities and operational efficiencies. The company’s recent Corporate Responsibility Report underscores its dedication to environmental, social, and governance (ESG) goals, highlighting meaningful progress in diverse talent representation, health equity initiatives, and cybersecurity enhancements.
For more insights into Amwell’s operations, financial performance, and upcoming events, visit their investor relations page at https://investors.amwell.com.
Amwell (NYSE: AMWL) announced a 1-for-20 reverse stock split of its Class A, B, and C common stock, effective on July 10, 2024, at 5:00 p.m. EDT. Trading on a split-adjusted basis will commence on July 11, 2024, under the same symbol, 'AMWL'.
The primary objective is to comply with the NYSE's $1.00 minimum average closing price requirement. This action will reduce the number of issued and outstanding shares across all classes by a factor of 20, without affecting the company's market capitalization.
Shareholders approved the reverse split at Amwell's annual meeting on June 18, 2024, choosing a split ratio between 1-for-10 and 1-for-20, with the final decision made by the Board on June 27, 2024. No fractional shares will be issued; instead, cash payments will be made for fractional entitlements.
The new CUSIP number for Class A shares will be 03044L 204 post-split. All outstanding options, warrants, and equity incentive plans will be adjusted accordingly. The par value remains unchanged at $0.01 per share.
Amwell (NYSE: AMWL), a leader in hybrid care enablement, announced the appointment of Ricky Goldwasser to its Board of Directors, effective June 13, 2024. Goldwasser, with a strong financial background and a successful career in healthcare investment and research, is expected to guide Amwell towards profitability and efficient cash flow. She replaces Deval Patrick, a long-time board member who played a important role in Amwell’s IPO and telehealth acceptance. CEO Ido Schoenberg highlighted Goldwasser's potential to help Amwell achieve its goals in the evolving healthcare landscape.
Amwell (NYSE: AMWL) announced that co-founder Roy Schoenberg is transitioning from his role as president and co-CEO to become Executive Vice Chairman of the Board. Ido Schoenberg will now serve as the sole CEO. Roy Schoenberg has been instrumental in the growth of Amwell, guiding the company through the COVID-19 pandemic and expanding its platform to over 100,000 active clinicians and millions of patients globally. He also spearheaded the development of the Amwell Converge platform aimed at integrating in-person and digital healthcare. The transition marks a shift from extensive R&D to a focus on operational efficiency, cash flow optimization, and profitable growth.
Amwell (NYSE: AMWL) announced that its Co-CEO and President, Roy Schoenberg, will speak at the Disability & Telehealth Conference on May 18, 2024, at 12:15 PST. The virtual conference will discuss barriers to telehealth for those with disabilities and innovative solutions for healthcare accessibility. Schoenberg will join leaders from Stanford Medicine, Stanford Health Care, Zoom, and Apple in the panel, 'Technology and Bold Solutions for Accessible Telehealth.' The session will focus on how big tech can drive innovations to meet the needs of patients with disabilities, aiming to improve health equity and accessibility. Amwell emphasizes improving access to quality healthcare through its WCAG-conformant platform, Amwell Converge™, featuring Interpreter Services and other accessibility functions.
Amwell® (NYSE: AMWL) reported financial results for the first quarter of 2024, highlighting its position as a growth healthcare company and a key player in healthcare software as a service. The earnings report can be viewed on the investor relations website. The company will host a conference call to discuss the results, providing access via webcast or phone.
Amwell, a leader in hybrid care enablement, released its 2024 Corporate Responsibility Report showcasing progress in environmental, social, and governance areas. The report highlights achievements in talent diversity, supplier diversity, health equity, employee engagement, energy efficiency, and cybersecurity. Amwell remains committed to transforming healthcare with responsible practices.
FAQ
What is the current stock price of American Well Corporation (AMWL)?
What is the market cap of American Well Corporation (AMWL)?
What is American Well Corporation's core business?
What recent achievements has Amwell made?
How does Amwell support mental health care?
What is the significance of Amwell's partnership with Amplar Health?
What financial improvements did Amwell report in Q3 2023?
What steps is Amwell taking to remain compliant with NYSE listing standards?
How does Amwell contribute to environmental sustainability?
What role does Dr. Cynthia Horner play at Amwell?
How does Amwell address workforce shortages in healthcare?
What is Amwell’s approach to corporate responsibility?
